Christakoudi, Sofia
Tsilidis, Konstantinos K.
Dossus, Laure
Rinaldi, Sabina
Weiderpass, Elisabete
Antoniussen, Christian S.
Dahm, Christina C.
Tjønneland, Anne
Mellemkjær, Lene
Katzke, Verena
Kaaks, Rudolf
Schulze, Matthias B.
Masala, Giovanna
Grioni, Sara
Panico, Salvatore
Tumino, Rosario
Sacerdote, Carlotta
May, Anne M.
Monninkhof, Evelyn M.
Quirós, J. Ramón
Bonet, Catalina
Sánchez, Maria-Jose
Amiano, Pilar
Chirlaque, María-Dolores
Guevara, Marcela
Rosendahl, Ann H.
Stocks, Tanja
Perez-Cornago, Aurora
Tin Tin, Sandar
Heath, Alicia K.
Aglago, Elom K.
Peruchet-Noray, Laia
Freisling, Heinz
Riboli, Elio
Article History
Received: 16 January 2023
Accepted: 10 June 2023
First Online: 19 June 2023
Declarations
:
: Where authors are identified as personnel of the International Agency for Research on Cancer / World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer / World Health Organization.
: This research was conducted according to the principles expressed in the Declaration of Helsinki. Approval for this study was obtained from the ethical review boards of the International Agency for Research on Cancer and from all participating EPIC centres. All EPIC participants provided written informed consent at baseline for use of their blood samples and data in future research. The EPIC Steering Committee approved this study in accordance with EPIC rules ExternalRef removed.
: Not applicable.
: Lene Mellemkjær has an immediate family member employed at Novo Nordisk, and has an immediate family member who owns stocks in Novo Nordisk. The other authors have no competing interests to declare.